Growth factors (GFs), chemokines, cytokines, and other signaling molecules all play a role in wound healing and tissue regeneration. Numerous breakthroughs in the subject have shed light on the mechanics of wound healing, and different technical solutions have been proposed as a result of these scientific advances. However, the mechanisms of tissue regeneration following wound injury have yet to be fully understood. Current advancements in unique drug delivery systems (DDSs) that release growth factors (GFs) offer a huge opportunity to develop new medicines or improve the efficacy of existing treatments. These breakthroughs are especially important in the field of regenerative medicine, which is tackling challenges like wound healing and skin restoration. To this purpose, biocompatible biomaterials have been intensively investigated in order to improve DDS in vivo integration, increase the bioactivity of released medications, and deliver bioactive compounds in a targeted and regulated manner.
Title : Small activating RNA from concept to phase 2 clinical trials
Nagy Habib, MiNA Therapeutics Ltd, United Kingdom
Title : Mechanical modulation of cell response in 3D bioprinted hydrogels
Ruben F Pereira, University of Porto, Portugal
Title : Electroactive polymer-based smart scaffolds for tissue engineering and regenerative medicine
Federico Carpi, University of Florence, Italy
Title : Graphene “Hastalex®”, butterfly, and stem cells are set to revolutionise the development of human organs.
Alexander Seifalian, NanoRegMed Ltd, BioScience Innovation Centre, United Kingdom
Title : Design of 3D bioengineered personalized scaffolds to potentiate bone ingrowth and angiogenic network for oral tissues reconstruction
Christiane Salgado , Institute of Research and Innovation in Health(i3S), Brazil
Title : RADA16-I based scaffolds for wound healing and regenerative medicine
Deptula Milena, Medical University of Gdansk, Poland